A study from 2012 reported the experiences with EGFR-testing in the first years after the implementation in 2010, that among 1058 NSCLC patients, 123 patients (11,6%) were EGFR-positive (16). This evidence concerns the gene EGFR and non-small cell lung carcinoma.